HUMAN TECHNOLOGY Co., Ltds stock price dropped 10 percent last week retail investors would not be happy - Simply Wall St
086450 Stock | KRW 16,680 90.00 0.54% |
About 53% of DongKook Pharmaceutical's investor base is interested to short. The analysis of current outlook of investing in DongKook Pharmaceutical Co suggests that many traders are impartial regarding DongKook Pharmaceutical's prospects. The current market sentiment, together with DongKook Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use DongKook Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
DongKook |
HUMAN TECHNOLOGY Co., Ltds stock price dropped 10 percent last week retail investors would not be happy Simply Wall St
Read at news.google.com
DongKook Pharmaceutical Fundamental Analysis
We analyze DongKook Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DongKook Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DongKook Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
DongKook Pharmaceutical is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
DongKook Pharmaceutical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with DongKook Pharmaceutical stock to make a market-neutral strategy. Peer analysis of DongKook Pharmaceutical could also be used in its relative valuation, which is a method of valuing DongKook Pharmaceutical by comparing valuation metrics with similar companies.
Peers
DongKook Pharmaceutical Related Equities
000660 | SK Hynix | 2.17 | ||||
034730 | SK Holdings | 0.92 | ||||
005935 | Samsung Electronics | 0.11 | ||||
005490 | POSCO Holdings | 0.18 | ||||
005930 | Samsung Electronics | 0.89 | ||||
005385 | Hyundai | 1.40 | ||||
005387 | Hyundai | 1.51 | ||||
005380 | Hyundai | 1.86 | ||||
000270 | Kia Corp | 2.85 |
Complementary Tools for DongKook Stock analysis
When running DongKook Pharmaceutical's price analysis, check to measure DongKook Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DongKook Pharmaceutical is operating at the current time. Most of DongKook Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of DongKook Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DongKook Pharmaceutical's price. Additionally, you may evaluate how the addition of DongKook Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |